CoChat
Sign Up
Cited by 124NF-κB Signaling PathwaysAdvanced Proteomics Techniques and ApplicationsT-cell and B-cell Immunology

The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.

Systems‐wide analysis of BCR signalosomes and downstream phosphorylation and ubiquitylation

Open access
Satpathy, Shankha, Wagner, Sebastian A, Beli, Petra, Gupta, Rajat, Kristiansen, Trine A, Malinova, Dessislava, Francavilla, Chiara, Tolar, Pavel, Bishop, Gail A, Hostager, Bruce S, Choudhary, Chunaram·2015·Molecular Systems Biology
DOI 10.15252/msb.20145880PMC PMC4501846
Open this paper in CoChat — free accountOpen PDF

Abstract

B‐cell receptor (BCR) signaling is essential for the development and function of B cells; however, the spectrum of proteins involved in BCR signaling is not fully known. Here we used quantitative mass spectrometry‐based proteomics to monitor the dynamics of BCR signaling complexes (signalosomes) and to investigate the dynamics of downstream phosphorylation and ubiquitylation signaling. We identify most of the previously known components of BCR signaling, as well as many proteins that have not yet been implicated in this system. BCR activation leads to rapid tyrosine phosphorylation and ubiquitylation of the receptor‐proximal signaling components, many of which are co‐regulated by both the modifications. We illustrate the power of multilayered proteomic analyses for discovering novel BCR signaling components by demonstrating that BCR‐induced phosphorylation of RAB7A at S72 prevents its association with effector proteins and with endo‐lysosomal compartments. In addition, we show that BCL10 is modified by LUBAC‐mediated linear ubiquitylation, and demonstrate an important function of LUBAC in BCR‐induced NF‐κB signaling. Our results offer a global and integrated view of BCR signaling, and the provided datasets can serve as a valuable resource for further understanding BCR signaling networks.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15252/msb.20145880

Cites

92 of 92 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Strategy for proteomic analysis of BCR signaling Analysis of BCR-induced phosphorylation and ubiquitylation. A20 cells were isotopically labeled using the SILAC approach. Control “light” labeled cells were mock-treated, and “medium” and “heavy” labeled cells were stimulated with α-IgG F(ab′)2 for 5 and 15 min, respectively. Di-Gly-modified (ubiquitylated), tyrosine-phosphorylated peptides were enriched sequentially using di-Gly-lysine- and phosphotyrosine-specific antibodies. Phosphorylated peptides were separately enriched using TiO2-based chromatography. All samples were analyzed using high-resolution mass spectrometry. Strategy for analyzing the dynamics of BCR signalosomes. “Medium” and “heavy” SILAC-labeled A20 cells were stimulated with biotinylated α-IgG F(ab′)2 for 5 and 15 min, respectively. Control cells (labeled with “light” SILAC) were mock-treated. Proteins associated with biotinylated α-IgG F(ab′)2-bound BCR signalosomes were affinity-enriched using streptavidin, separated by SDS–PAGE, and analyzed by LC-MS/MS. Validation of BCR signaling activation. Stimulation of BCR signaling in A20 cells was confirmed using the indicated phosphorylation site-specific antibodies that recognize the activated forms of BTK, ERK1/2, and AKT kinases.
Figure 1 Strategy for proteomic analysis of BCR signaling Analysis of BCR-induced phosphorylation and ubiquitylation. A20 cells were isotopically labeled using the SILAC approach. Control “light” labeled cells were mock-treated, and “medium” and “heavy” labeled cells were stimulated with α-IgG F(ab′)2 for 5 and 15 min, respectively. Di-Gly-modified (ubiquitylated), tyrosine-phosphorylated peptides were enriched sequentially using di-Gly-lysine- and phosphotyrosine-specific antibodies. Phosphorylated peptides were separately enriched using TiO2-based chromatography. All samples were analyzed using high-resolution mass spectrometry. Strategy for analyzing the dynamics of BCR signalosomes. “Medium” and “heavy” SILAC-labeled A20 cells were stimulated with biotinylated α-IgG F(ab′)2 for 5 and 15 min, respectively. Control cells (labeled with “light” SILAC) were mock-treated. Proteins associated with biotinylated α-IgG F(ab′)2-bound BCR signalosomes were affinity-enriched using streptavidin, separated by SDS–PAGE, and analyzed by LC-MS/MS. Validation of BCR signaling activation. Stimulation of BCR signaling in A20 cells was confirmed using the indicated phosphorylation site-specific antibodies that recognize the activated forms of BTK, ERK1/2, and AKT kinases.CC BY · PubMed Central
Figure 2 Proteomic analysis of BCR signalosomes A The Venn diagram shows the overlap between the proteins that were enriched in BCR signalosomes at 5 and 15 min. B A network view of proteins present in BCR signalosome. Proteins are color-coded based on their association with BCR signalosomes at 5 or 15 min after BCR cross-linking. C Validation of the dynamic association of proteins with BCR signalosomes. A20 cells were stimulated with biotinylated α-IgG F(ab′)2 for the indicated time points, the signalosomes were isolated by streptavidin pull-downs, and enrichment of the indicated proteins was analyzed by immunoblotting. D, E ANKRD13A associates with BCR signalosomes. A20 cells were transiently transfected with GFP-tagged ANKRD13A WT and the ANRKD13A ΔUIM mutant (D), or ANKRD13A WT and ANKRD13A UIM3/4 mutant (E). BCR signalosomes were isolated as described in (C), and the enrichment of ANKRD13A was probed using α-GFP antibody. The expression of GFP-tagged ANKRD13A WT, ANRKD13A ΔUIM, and ANKRD13A UIM3/4 mutants in the input material was verified.
Figure 2 Proteomic analysis of BCR signalosomes A The Venn diagram shows the overlap between the proteins that were enriched in BCR signalosomes at 5 and 15 min. B A network view of proteins present in BCR signalosome. Proteins are color-coded based on their association with BCR signalosomes at 5 or 15 min after BCR cross-linking. C Validation of the dynamic association of proteins with BCR signalosomes. A20 cells were stimulated with biotinylated α-IgG F(ab′)2 for the indicated time points, the signalosomes were isolated by streptavidin pull-downs, and enrichment of the indicated proteins was analyzed by immunoblotting. D, E ANKRD13A associates with BCR signalosomes. A20 cells were transiently transfected with GFP-tagged ANKRD13A WT and the ANRKD13A ΔUIM mutant (D), or ANKRD13A WT and ANKRD13A UIM3/4 mutant (E). BCR signalosomes were isolated as described in (C), and the enrichment of ANKRD13A was probed using α-GFP antibody. The expression of GFP-tagged ANKRD13A WT, ANRKD13A ΔUIM, and ANKRD13A UIM3/4 mutants in the input material was verified.CC BY · PubMed Central
Figure 3 Analysis of BCR-regulated phosphorylation An overview of the BCR-regulated phosphoproteome. The table shows the number of the identified phosphorylation sites, and the number of sites that were up- (≥ SILAC ratio 2) or downregulated (≤ SILAC ratio 0.5) after 5 and 15 min of BCR stimulation. Functional annotation of the BCR-upregulated phosphoproteome. The bar graph shows GO biological processes (GOBP) terms that were significantly enriched in BCR-upregulated phosphoproteome. A diagram of the BCR signaling pathway. The proteins with upregulated phosphorylation sites in the pathway are colored, and the color gradient indicates the magnitude of phosphorylation increase. The modified amino acids (tyrosine or serine/threonine) are color-coded as circles, and the numbers of BCR-upregulated sites are indicated within the circles. Proteins with light yellow color were either not quantified or did not contain BCR-upregulated phosphorylation.
Figure 3 Analysis of BCR-regulated phosphorylation An overview of the BCR-regulated phosphoproteome. The table shows the number of the identified phosphorylation sites, and the number of sites that were up- (≥ SILAC ratio 2) or downregulated (≤ SILAC ratio 0.5) after 5 and 15 min of BCR stimulation. Functional annotation of the BCR-upregulated phosphoproteome. The bar graph shows GO biological processes (GOBP) terms that were significantly enriched in BCR-upregulated phosphoproteome. A diagram of the BCR signaling pathway. The proteins with upregulated phosphorylation sites in the pathway are colored, and the color gradient indicates the magnitude of phosphorylation increase. The modified amino acids (tyrosine or serine/threonine) are color-coded as circles, and the numbers of BCR-upregulated sites are indicated within the circles. Proteins with light yellow color were either not quantified or did not contain BCR-upregulated phosphorylation.CC BY · PubMed Central
Figure 4 BCR-induced phosphorylation of RAB7A regulates its subcellular localization and effector binding Identification of BCR-inducible RAB7A S72 phosphorylation. The MS spectrum (the left panel) shows the relative abundance of RAB7A S72 containing phosphopeptide at 5 and 15 min after the stimulation, and the MS/MS spectrum (the right panel) shows fragment ions of the identified peptide. Subcellular localization of RAB7A phosphorylation mutants in B cells. Primary B cells were isolated from mouse spleen and infected with retroviruses expressing RAB7A WT or the indicated mutants fused with GFP. Cells were fixed with paraformaldehyde and stained with α-LAMP1, and epifluorescence images were acquired. Images show maximum projection of z-stacks of the cells. Subcellular localization of RAB7A phosphorylation mutants in HeLa cells. The cells were co-transfected with FLAG-RILP and RAB7A or the indicated mutants fused with GFP. Cells were fixed, permeabilized, and stained with α-FLAG and α-LAMP1 antibodies to detect the exogenously expressed RILP and the endogenous LAMP1. Strategy for identifying RAB7A interacting proteins. In experiment 1 (Exp 1), SILAC-labeled HeLa cells were transfected with GFP-RAB7A- or GFP-expressing plasmid vector to identify RAB7A interacting proteins. In a separate experiment (Exp 2), the interaction profile of GFP-RAB7A S72E was compared to GFP-RAB7A S72A. Interaction profile of the RAB7A and the mutants. The bar graph shows the logarithmized SILAC ratios of the indicated RAB7A-binding proteins that were enriched (≥ 2-fold) with GFP-RAB7A compared to their levels in control immunoprecipitation (Exp 1), and their relative de-enrichment in GFP-RAB7A S72E compared to GFP-RAB7A S72A (Exp 2).
Figure 4 BCR-induced phosphorylation of RAB7A regulates its subcellular localization and effector binding Identification of BCR-inducible RAB7A S72 phosphorylation. The MS spectrum (the left panel) shows the relative abundance of RAB7A S72 containing phosphopeptide at 5 and 15 min after the stimulation, and the MS/MS spectrum (the right panel) shows fragment ions of the identified peptide. Subcellular localization of RAB7A phosphorylation mutants in B cells. Primary B cells were isolated from mouse spleen and infected with retroviruses expressing RAB7A WT or the indicated mutants fused with GFP. Cells were fixed with paraformaldehyde and stained with α-LAMP1, and epifluorescence images were acquired. Images show maximum projection of z-stacks of the cells. Subcellular localization of RAB7A phosphorylation mutants in HeLa cells. The cells were co-transfected with FLAG-RILP and RAB7A or the indicated mutants fused with GFP. Cells were fixed, permeabilized, and stained with α-FLAG and α-LAMP1 antibodies to detect the exogenously expressed RILP and the endogenous LAMP1. Strategy for identifying RAB7A interacting proteins. In experiment 1 (Exp 1), SILAC-labeled HeLa cells were transfected with GFP-RAB7A- or GFP-expressing plasmid vector to identify RAB7A interacting proteins. In a separate experiment (Exp 2), the interaction profile of GFP-RAB7A S72E was compared to GFP-RAB7A S72A. Interaction profile of the RAB7A and the mutants. The bar graph shows the logarithmized SILAC ratios of the indicated RAB7A-binding proteins that were enriched (≥ 2-fold) with GFP-RAB7A compared to their levels in control immunoprecipitation (Exp 1), and their relative de-enrichment in GFP-RAB7A S72E compared to GFP-RAB7A S72A (Exp 2).CC BY · PubMed Central
Figure 5 The BCR-induced ubiquitylome The overlap between BCR-regulated di-Gly-modified (ubiquitylation) sites. The Venn diagram shows the overlap of up- and downregulated sites after 5 or 15 min of BCR stimulation. The functional annotation of the BCR-upregulated ubiquitylome. The bar graph indicates GO biological processes (GOBP), GO cellular compartments (GOCC), and GO molecular processes (GOMP) terms that were significantly enriched among the proteins containing BCR-upregulated di-Gly-modified sites. Network analysis of the BCR-regulated ubiquitylome. The network shows proteins that contained BCR-upregulated di-Gly-modified sites at one or both of the time points. The proteins that also harbored BCR-induced phosphorylation are indicated in red type.
Figure 5 The BCR-induced ubiquitylome The overlap between BCR-regulated di-Gly-modified (ubiquitylation) sites. The Venn diagram shows the overlap of up- and downregulated sites after 5 or 15 min of BCR stimulation. The functional annotation of the BCR-upregulated ubiquitylome. The bar graph indicates GO biological processes (GOBP), GO cellular compartments (GOCC), and GO molecular processes (GOMP) terms that were significantly enriched among the proteins containing BCR-upregulated di-Gly-modified sites. Network analysis of the BCR-regulated ubiquitylome. The network shows proteins that contained BCR-upregulated di-Gly-modified sites at one or both of the time points. The proteins that also harbored BCR-induced phosphorylation are indicated in red type.CC BY · PubMed Central
Figure 6 BCR stimulation induces linear ubiquitylation of BCL10 A Strategy for the identification of BCR-regulated ubiquitylated proteins. SILAC-labeled A20 cells were stimulated with α-IgG F(ab′)2 for the indicated times, and ubiquitylated proteins were affinity-enriched using tandem ubiquitin-binding entities (TUBE)-based pull-downs B Interaction network of BCR-induced ubiquitylated proteins. The network shows interaction among the proteins that were significantly enriched in TUBE pull-downs from BCR-stimulated cells compared to proteins pulled down from mock-treated control cells. Blue circles indicate the proteins which were also identified as BCR-upregulated in our di-Gly dataset. The dotted box indicates members of the CBM complex. C BCR stimulation increases the abundance of Met1-linked ubiquitin (Met1-UB). The plot shows the SILAC ratios of peptide corresponding to Met1-UB chains in the TUBE pull-downs from (A). The error bars represent mean ± SEM of the SILAC ratios. D BCR stimulation increases the abundance of linear ubiquitin peptide. The MS spectrum shows the relative abundance of the peptide (GGMQIFVK) corresponding to Met1-UB in TUBE pull-downs from unstimulated cells, or after 5 or 15 min of BCR stimulation. E, F Identification of BCR-regulated linear ubiquitylated proteins. Schematic presentation of the strategy used for SILAC-based Met1-SUB pull-downs (E). The scatter plot shows proteins identified in Met1-SUB pull-downs (F). The gray background indicates proteins that were identified in the pull-downs independent of BCR stimulation, and the red dots indicate proteins that were enriched after 5 and 15 min of BCR stimulation.
Figure 6 BCR stimulation induces linear ubiquitylation of BCL10 A Strategy for the identification of BCR-regulated ubiquitylated proteins. SILAC-labeled A20 cells were stimulated with α-IgG F(ab′)2 for the indicated times, and ubiquitylated proteins were affinity-enriched using tandem ubiquitin-binding entities (TUBE)-based pull-downs B Interaction network of BCR-induced ubiquitylated proteins. The network shows interaction among the proteins that were significantly enriched in TUBE pull-downs from BCR-stimulated cells compared to proteins pulled down from mock-treated control cells. Blue circles indicate the proteins which were also identified as BCR-upregulated in our di-Gly dataset. The dotted box indicates members of the CBM complex. C BCR stimulation increases the abundance of Met1-linked ubiquitin (Met1-UB). The plot shows the SILAC ratios of peptide corresponding to Met1-UB chains in the TUBE pull-downs from (A). The error bars represent mean ± SEM of the SILAC ratios. D BCR stimulation increases the abundance of linear ubiquitin peptide. The MS spectrum shows the relative abundance of the peptide (GGMQIFVK) corresponding to Met1-UB in TUBE pull-downs from unstimulated cells, or after 5 or 15 min of BCR stimulation. E, F Identification of BCR-regulated linear ubiquitylated proteins. Schematic presentation of the strategy used for SILAC-based Met1-SUB pull-downs (E). The scatter plot shows proteins identified in Met1-SUB pull-downs (F). The gray background indicates proteins that were identified in the pull-downs independent of BCR stimulation, and the red dots indicate proteins that were enriched after 5 and 15 min of BCR stimulation.CC BY · PubMed Central
Figure 7 Validation of BCL10 linear ubiquitylation A, B Validation of BCR stimulation-dependent linear ubiquitylation of BCL10. BCL10 was immunoprecipitated from BCR-stimulated and unstimulated control A20 cells and immunoblotted with LUB9 antibody that binds to linear ubiquitin (A, the upper panel). From the same cell lysates, linear ubiquitylated proteins were isolated using Met1-SUB and probed with BCL10 (A, the lower panel). The latter approach was also used to confirm BCR-induced linear ubiquitylation of BCL10 in A20.2J cells (B). The blots at the bottom of the figure show the expression levels of BCL10 and actin in the input material used for BCL10 immunoprecipitation and Met1-SUB pull-downs. C BCL10 ubiquitylation is sensitive to linear and K63 linkage-specific deubiquitylases. Linearly ubiquitylated proteins were isolated from BCR stimulated cells with Met1-SUB, treated with the indicated deubiquitylases, and subsequently immunostained with antibodies recognizing BCL10, or ubiquitin. The blots at the bottom of the figures show the expression levels of BCL10 and actin in the input material used for Met1-SUB pull-downs.
Figure 7 Validation of BCL10 linear ubiquitylation A, B Validation of BCR stimulation-dependent linear ubiquitylation of BCL10. BCL10 was immunoprecipitated from BCR-stimulated and unstimulated control A20 cells and immunoblotted with LUB9 antibody that binds to linear ubiquitin (A, the upper panel). From the same cell lysates, linear ubiquitylated proteins were isolated using Met1-SUB and probed with BCL10 (A, the lower panel). The latter approach was also used to confirm BCR-induced linear ubiquitylation of BCL10 in A20.2J cells (B). The blots at the bottom of the figure show the expression levels of BCL10 and actin in the input material used for BCL10 immunoprecipitation and Met1-SUB pull-downs. C BCL10 ubiquitylation is sensitive to linear and K63 linkage-specific deubiquitylases. Linearly ubiquitylated proteins were isolated from BCR stimulated cells with Met1-SUB, treated with the indicated deubiquitylases, and subsequently immunostained with antibodies recognizing BCL10, or ubiquitin. The blots at the bottom of the figures show the expression levels of BCL10 and actin in the input material used for Met1-SUB pull-downs.CC BY · PubMed Central
Figure 8 Functional analysis of BCL10 linear ubiquitylation A HOIP interacts with BCL10. A20.2J HOIP−/− cells reconstituted with the full-length FLAG-HOIP were stimulated with α-IgG for the indicated times, HOIP was immunoprecipitated with α-FLAG antibody, and the immunoprecipitates were immunostained with BCL10 antibody. The amounts of immunoprecipitated HOIP, and equal expression of FLAG-HOIP and BCL10 in whole-cell lysates used for the IPs, are shown in the lower blots. The asterisk indicates unmodified BCL10. B HOIP is required for BCL10 linear ubiquitylation. A20.2J, A20.2J HOIP−/−, and A20.2J HOIP−/− cells expressing the HOIP full-length or the indicated HOIP mutants were stimulated with α-IgG followed by Met1-SUB pull-down and immunoblotting as described in Fig7A. C TRAF6 is required for BCL10 linear ubiquitylation. A20.2J wild-type and TRAF6−/− cells were stimulated with α-IgG for 10 min, and linear ubiquitylated proteins were pulled down with Met1-SUB and immunoblotted with BCL10 and ubiquitin antibodies. Equal expression of BCL10 and actin was verified in the input material. D HOIP and TRAF6 function is important for BCR-induced IκB phosphorylation. A20.2J wild-type, HOIP−/−, TRAF6−/−, and HOIP−/− cells expressing HOIP ΔRBR were stimulated with α-IgG for the indicated time points, and lysates were immunostained with pIκB and IκB antibodies. Actin and vinculin staining serves as loading control. E, F BCL10 linear ubiquitin fusion protein activates NF-κB. HEK293T cells were co-transfected with increasing amount (0.5, 1 or 2 μg) of BCL10, or BCL10-LinUBL73P-4X construct together with pNF-κB Luc and pRL-TK Renilla. NF-κB transcriptional activity was measured 24 h later using Dual-Glo® Luciferase Assay System (Promega). In (F), NF-κB transcriptional activity was measured in HEK293T cells co-transfected with 1 μg of the indicated plasmids. Error bars indicate mean ± SEM of 3 (E) or 2 (F) independent experiments. Statistical significance was determined by two-tailed Student's t-test.
Figure 8 Functional analysis of BCL10 linear ubiquitylation A HOIP interacts with BCL10. A20.2J HOIP−/− cells reconstituted with the full-length FLAG-HOIP were stimulated with α-IgG for the indicated times, HOIP was immunoprecipitated with α-FLAG antibody, and the immunoprecipitates were immunostained with BCL10 antibody. The amounts of immunoprecipitated HOIP, and equal expression of FLAG-HOIP and BCL10 in whole-cell lysates used for the IPs, are shown in the lower blots. The asterisk indicates unmodified BCL10. B HOIP is required for BCL10 linear ubiquitylation. A20.2J, A20.2J HOIP−/−, and A20.2J HOIP−/− cells expressing the HOIP full-length or the indicated HOIP mutants were stimulated with α-IgG followed by Met1-SUB pull-down and immunoblotting as described in Fig7A. C TRAF6 is required for BCL10 linear ubiquitylation. A20.2J wild-type and TRAF6−/− cells were stimulated with α-IgG for 10 min, and linear ubiquitylated proteins were pulled down with Met1-SUB and immunoblotted with BCL10 and ubiquitin antibodies. Equal expression of BCL10 and actin was verified in the input material. D HOIP and TRAF6 function is important for BCR-induced IκB phosphorylation. A20.2J wild-type, HOIP−/−, TRAF6−/−, and HOIP−/− cells expressing HOIP ΔRBR were stimulated with α-IgG for the indicated time points, and lysates were immunostained with pIκB and IκB antibodies. Actin and vinculin staining serves as loading control. E, F BCL10 linear ubiquitin fusion protein activates NF-κB. HEK293T cells were co-transfected with increasing amount (0.5, 1 or 2 μg) of BCL10, or BCL10-LinUBL73P-4X construct together with pNF-κB Luc and pRL-TK Renilla. NF-κB transcriptional activity was measured 24 h later using Dual-Glo® Luciferase Assay System (Promega). In (F), NF-κB transcriptional activity was measured in HEK293T cells co-transfected with 1 μg of the indicated plasmids. Error bars indicate mean ± SEM of 3 (E) or 2 (F) independent experiments. Statistical significance was determined by two-tailed Student's t-test.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 92 references

Cited by

Sorted by citations

See all 124

Related

Metadata

Authors
Satpathy, S., Wagner, S. A., Beli, P., Gupta, R., Kristiansen, T. A., Malinova, D., Francavilla, C., Tolar, P., Bishop, G. A., Hostager, B. S., & Choudhary, C.
Affiliations
  • University of Copenhagen (DK)
  • National Institute for Medical Research (GB)
  • University of Iowa (US)
Corresponding author
Choudhary, Chunaram
ORCID
Venue
Molecular Systems Biology
Publisher
Springer Science and Business Media LLC
Published
2015-06-01
Volume
11
Issue
6
Pages
810-810
ISSN
1744-4292 (ISSN-L)
DOI
10.15252/msb.20145880
PMC
PMC4501846
OpenAlex
W1894912312
Cited by
124
References
92
Citations by year
2026: 3 · 2025: 3 · 2024: 9 · 2023: 10 · 2022: 9 · 2021: 17 · 2020: 19 · 2019: 7 · 2018: 14 · 2017: 15 · 2016: 16 · 2015: 2
FWCI
5.18
Type
journal article
Language
en
Open access
Licence
Locations
  • Molecular Systems Biology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
  • Research Explorer (The University of Manchester) (submittedVersion)
Funders
  • EMBO long‐term Fellowship
  • Novo Nordisk Foundation (NNF14CC0001)
  • EMBO Young Investigator Program
  • Sapere Aude Program
  • Danish Council for Independent Research
  • Biological Sciences Funding Program
  • Medical Research Council UK (U117597138)
  • LOEWE Program Ubiquitin Networks (Ub‐Net) of the State of Hesse
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
  • Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords
B cell receptor signaling, signalosome, tyrosine phosphorylation, ubiquitination, LUBAC, Rab7, BCL10, NF-κB signaling, B cell development
MeSH terms
B-Cell CLL-Lymphoma 10 Protein, B-Lymphocytes, HeLa Cells, Humans, Membrane Proteins, Phosphorylation, Receptors, Antigen, B-Cell, Signal Transduction, NF-kappa B, Proteomics, Ubiquitin-Protein Ligases, Adaptor Proteins, Signal Transducing, Ubiquitination, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review